Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
16.89
+0.12 (0.72%)
At close: Sep 18, 2026, 4:00 PM EDT
16.84
-0.05 (-0.30%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $722.91 million as of September 18, 2026. Its market cap has increased by 188.89% in one year.
Market Cap
722.91M
Enterprise Value
552.75M
1-Year Change
188.89%
Ranking
Category
Stock Price
$16.89
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $722.91M, an increase of 134.11%. That is a compound annual growth rate of 96.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 722.91M | 211.79% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BlossomHill Therapeutics | 788.77M |
| Design Therapeutics | 766.00M |
| Pharming Group | 744.14M |
| Silence Therapeutics | 734.55M |
| DBV Technologies | 729.61M |
| Nuvectis Pharma | 716.79M |
| MiMedx Group | 695.28M |
| Zevra Therapeutics | 689.45M |